Literature DB >> 7669555

The genetic analysis of ovarian cancer.

A N Shelling1, I E Cooke, T S Ganesan.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7669555      PMCID： PMC2033888          DOI： 10.1038/bjc.1995.367

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  102 in total

1.  Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.

Authors:  T Yamaguchi; J Toguchida; T Yamamuro; Y Kotoura; N Takada; N Kawaguchi; Y Kaneko; Y Nakamura; M S Sasaki; K Ishizaki
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

2.  Human epithelial ovarian cancer allelotype.

Authors:  W Cliby; S Ritland; L Hartmann; M Dodson; K C Halling; G Keeney; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

3.  Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.

Authors:  M K Dodson; W A Cliby; H J Xu; K A DeLacey; S X Hu; G L Keeney; J Li; K C Podratz; R B Jenkins; W F Benedict
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

4.  Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation.

Authors:  M Kiechle-Schwarz; T Bauknecht; T Wienker; L Walz; A Pfleiderer
Journal:  Cancer       Date:  1993-10-15       Impact factor: 6.860

5.  Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.

Authors:  M K Dodson; L C Hartmann; W A Cliby; K A DeLacey; G L Keeney; S R Ritland; J Q Su; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

6.  p53 mutations in ovarian cancer: a late event?

Authors:  R Mazars; P Pujol; T Maudelonde; P Jeanteur; C Theillet
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

7.  Altered chromosome 6 in immortal human fibroblasts.

Authors:  K Hubbard-Smith; P Patsalis; J R Pardinas; K K Jha; A S Henderson; H L Ozer
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

8.  Molecular mechanisms possibly affecting WT1 function in human ovarian tumors.

Authors:  A Viel; F Giannini; E Capozzi; V Canzonieri; C Scarabelli; A Gloghini; M Boiocchi
Journal:  Int J Cancer       Date:  1994-05-15       Impact factor: 7.396

9.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

Authors:  S D Merajver; T M Pham; R F Caduff; M Chen; E L Poy; K A Cooney; B L Weber; F S Collins; C Johnston; T S Frank
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

10.  p53 gene mutations and protein accumulation in human ovarian cancer.

Authors:  J Kupryjańczyk; A D Thor; R Beauchamp; V Merritt; S M Edgerton; D A Bell; D W Yandell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205
View more
  19 in total

1.  An integrated genetic map of Chromosome 6.

Authors:  I E Cooke; S A Cox; A N Shelling; V G Le Meuth; N K Spurr; T S Ganesan
Journal:  Mamm Genome       Date:  1996-02       Impact factor: 2.957

2.  Genomic aberrations in borderline ovarian tumors.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Hege K Andersen; Vera M Abeler; Ben Davidson; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Transl Med       Date:  2010-02-26       Impact factor: 5.531

3.  The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer.

Authors:  Dirk O Bauerschlag; Christian Schem; Marion T Weigel; Constantin Von Kaisenberg; Alexander Strauss; Thomas Bauknecht; Nicolai Maass; Ivo Meinhold-Heerlein
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

Review 4.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

5.  Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer.

Authors:  M Suzuki; S Saito; Y Saga; M Ohwada; I Sato
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

6.  Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.

Authors:  A P M Jongsma; J M J Piek; R P Zweemer; R H M Verheijen; J W T Klein Gebbinck; G J van Kamp; I J Jacobs; P Shaw; P J van Diest; P Kenemans
Journal:  Mol Pathol       Date:  2002-10

Review 7.  Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2008-04       Impact factor: 2.762

Review 8.  Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.

Authors:  Robert J Kurman; Kala Visvanathan; Richard Roden; T C Wu; Ie-Ming Shih
Journal:  Am J Obstet Gynecol       Date:  2008-04       Impact factor: 8.661

9.  Evaluation of FHIT gene alterations in ovarian cancer.

Authors:  F Buttitta; A Marchetti; O Radi; G Bertacca; S Pellegrini; A Gadducci; A R Genazzani; G Bevilacqua
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma.

Authors:  June Y Hou; Alicia Rodriguez-Gabin; Leleesha Samaraweera; Leleesha Samaweera; Rachel Hazan; Gary L Goldberg; Susan Band Horwitz; Hayley M McDaid
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.